Lung damage after TB: a new study tests whether rehabilitation can restore breathing and quality of life
NCT ID NCT07731009
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
Many people who recover from tuberculosis are left with long-term lung damage, known as post-tuberculosis lung disease (PTLD), which can cause breathing problems and reduce quality of life. This study follows 760 participants—including people with active TB, those with established PTLD, and healthy volunteers—to understand why some develop PTLD and how to prevent or treat it. Researchers will also test a comprehensive pulmonary rehabilitation programme combining exercise, breathing exercises, education, and emotional support to see if it improves physical capacity and well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a multicomponent pulmonary rehabilitation programme including exercise training, respiratory physiotherapy, health education, and psychosocial support
- What this could lead to
- If successful, this could lead to better ways to prevent, detect early, and manage lung damage after tuberculosis, improving long-term health and quality of life for survivors.
- What could go wrong
- This is an observational and interventional study without a control group for the rehabilitation arm, so results may be influenced by other factors. The long follow-up may also lead to participant dropout.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new patient cohort unlock the secrets of TB treatment success?
- Shorter TB treatment: a 4-Month regimen put to the test
- Can a more powerful antibiotic clear TB faster? a trial puts rifapentine to the test.
- Could a simple screening strategy uncover hidden TB in COPD patients?
- Talking it out: could counseling be the key to beating TB?
- New TB vaccine aims to prevent active lung disease in adults